+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Healthcare Contract Development & Manufacturing Organization Market Research Report by Services, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 144 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5456915
UP TO OFF until Dec 31st 2022
The United States Healthcare Contract Development & Manufacturing Organization Market size was estimated at USD 50.41 billion in 2021, USD 59.93 billion in 2022, and is projected to grow at a CAGR of 15.16% to reach USD 117.61 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Healthcare Contract Development & Manufacturing Organization to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Services, the market was studied across Clinical, Contract Development, Contract Manufacturing, and Laboratory Services. The Clinical is further studied across Phase I, Phase II, Phase III, and Phase IV. The Contract Development is further studied across Preclinical. The Preclinical is further studied across Bioanalysis and DMPK studies and Toxicology Testing. The Contract Manufacturing is further studied across API/Bulk Drugs, Finished Dose Formulations, and Medical Device. The Medical Device is further studied across Class I, Class II, and Class III. The Laboratory Services is further studied across Analytical Services and Bioanalytical Services.
  • Based on End-User, the market was studied across Big Pharmaceutical Companies, Generic Pharmaceutical Companies, and Small & Medium-Sized Pharmaceutical Companies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Healthcare Contract Development & Manufacturing Organization market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Contract Development & Manufacturing Organization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Healthcare Contract Development & Manufacturing Organization Market, including Catalent Inc., Covance Inc., Flex, IQVIA Holdings Inc., Jabil, Lonza Group Ltd., Recipharm AB, Sanmina Corporation, Siegfried Holding AG, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Healthcare Contract Development & Manufacturing Organization Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Healthcare Contract Development & Manufacturing Organization Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Healthcare Contract Development & Manufacturing Organization Market?
4. What is the competitive strategic window for opportunities in the United States Healthcare Contract Development & Manufacturing Organization Market?
5. What are the technology trends and regulatory frameworks in the United States Healthcare Contract Development & Manufacturing Organization Market?
6. What is the market share of the leading vendors in the United States Healthcare Contract Development & Manufacturing Organization Market?
7. What modes and strategic moves are considered suitable for entering the United States Healthcare Contract Development & Manufacturing Organization Market?
Frequently Asked Questions about the U.S. Healthcare Contract Development & Manufacturing Organization Market

What is the estimated value of the U.S. Healthcare Contract Development & Manufacturing Organization Market?

The U.S. Healthcare Contract Development & Manufacturing Organization Market was estimated to be valued at $50.41 Billion in 2021.

What is the growth rate of the U.S. Healthcare Contract Development & Manufacturing Organization Market?

The growth rate of the U.S. Healthcare Contract Development & Manufacturing Organization Market is 15.1%, with an estimated value of $117.61 Billion by 2027.

What is the forecasted size of the U.S. Healthcare Contract Development & Manufacturing Organization Market?

The U.S. Healthcare Contract Development & Manufacturing Organization Market is estimated to be worth $117.61 Billion by 2027.

Who are the key companies in the U.S. Healthcare Contract Development & Manufacturing Organization Market?

Key companies in the U.S. Healthcare Contract Development & Manufacturing Organization Market include Catalent Inc., Covance Inc., Flex, IQVIA Holdings Inc., Jabil, Lonza Group Ltd., Recipharm AB, Sanmina Corporation and Thermo Fisher Scientific Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Healthcare Contract Development & Manufacturing Organization Market, by Services
6.1. Introduction
6.2. Clinical
6.3.1. Phase I
6.3.2. Phase II
6.3.3. Phase III
6.3.4. Phase IV
6.3. Contract Development
6.4.1. Preclinical
6.4.2.1. Bioanalysis and DMPK studies
6.4.2.2. Toxicology Testing
6.4. Contract Manufacturing
6.5.1. API/Bulk Drugs
6.5.2. Finished Dose Formulations
6.5.3. Medical Device
6.5.4.1. Class I
6.5.4.2. Class II
6.5.4.3. Class III
6.5. Laboratory Services
6.6.1. Analytical Services
6.6.2. Bioanalytical Services
7. Healthcare Contract Development & Manufacturing Organization Market, by End-User
7.1. Introduction
7.2. Big Pharmaceutical Companies
7.3. Generic Pharmaceutical Companies
7.4. Small & Medium-Sized Pharmaceutical Companies
8. California Healthcare Contract Development & Manufacturing Organization Market
8.1. Introduction
9. Florida Healthcare Contract Development & Manufacturing Organization Market
9.1. Introduction
10. Illinois Healthcare Contract Development & Manufacturing Organization Market
10.1. Introduction
11. New York Healthcare Contract Development & Manufacturing Organization Market
11.1. Introduction
12. Ohio Healthcare Contract Development & Manufacturing Organization Market
12.1. Introduction
13. Pennsylvania Healthcare Contract Development & Manufacturing Organization Market
13.1. Introduction
14. Texas Healthcare Contract Development & Manufacturing Organization Market
14.1. Introduction
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Catalent Inc.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Covance Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Flex
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. IQVIA Holdings Inc.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Jabil
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Lonza Group Ltd.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Recipharm AB
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Sanmina Corporation
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Siegfried Holding AG
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Thermo Fisher Scientific Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 6. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET DYNAMICS
FIGURE 8. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2021 VS 2027 (USD BILLION)
FIGURE 10. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICES, 2027
FIGURE 11. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2027 (USD BILLION)
FIGURE 12. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, 2018-2027 (USD BILLION)
FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, 2018-2027 (USD BILLION)
FIGURE 14. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, 2018-2027 (USD BILLION)
FIGURE 15. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, 2018-2027 (USD BILLION)
FIGURE 16. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2027 (USD BILLION)
FIGURE 17. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2027 (USD BILLION)
FIGURE 18. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, 2018-2027 (USD BILLION)
FIGURE 19. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2027 (USD BILLION)
FIGURE 20. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2027 (USD BILLION)
FIGURE 21. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, 2018-2027 (USD BILLION)
FIGURE 22. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2027 (USD BILLION)
FIGURE 23. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, 2018-2027 (USD BILLION)
FIGURE 24. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, 2018-2027 (USD BILLION)
FIGURE 25. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, 2018-2027 (USD BILLION)
FIGURE 26. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, 2018-2027 (USD BILLION)
FIGURE 27. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2027 (USD BILLION)
FIGURE 28. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2027 (USD BILLION)
FIGURE 29. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, 2018-2027 (USD BILLION)
FIGURE 30. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 31. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2021 VS 2027 (USD BILLION)
FIGURE 32. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 33. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
FIGURE 34. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
FIGURE 35. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
FIGURE 36. CALIFORNIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. FLORIDA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. ILLINOIS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. NEW YORK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. OHIO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. PENNSYLVANIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. TEXAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 44. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 45. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 5. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 6. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2027 (USD BILLION)
TABLE 7. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY STATE, 2018-2027 (USD BILLION)
TABLE 8. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, 2018-2027 (USD BILLION)
TABLE 9. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY STATE, 2018-2027 (USD BILLION)
TABLE 10. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, 2018-2027 (USD BILLION)
TABLE 11. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY STATE, 2018-2027 (USD BILLION)
TABLE 12. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, 2018-2027 (USD BILLION)
TABLE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY STATE, 2018-2027 (USD BILLION)
TABLE 14. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, 2018-2027 (USD BILLION)
TABLE 15. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY STATE, 2018-2027 (USD BILLION)
TABLE 16. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2027 (USD BILLION)
TABLE 17. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY STATE, 2018-2027 (USD BILLION)
TABLE 18. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2027 (USD BILLION)
TABLE 19. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY STATE, 2018-2027 (USD BILLION)
TABLE 20. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, 2018-2027 (USD BILLION)
TABLE 21. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY STATE, 2018-2027 (USD BILLION)
TABLE 22. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2027 (USD BILLION)
TABLE 23. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY STATE, 2018-2027 (USD BILLION)
TABLE 24. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2027 (USD BILLION)
TABLE 25. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY STATE, 2018-2027 (USD BILLION)
TABLE 26. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, 2018-2027 (USD BILLION)
TABLE 27. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, BY STATE, 2018-2027 (USD BILLION)
TABLE 28. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2027 (USD BILLION)
TABLE 29. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY STATE, 2018-2027 (USD BILLION)
TABLE 30. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, 2018-2027 (USD BILLION)
TABLE 31. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, BY STATE, 2018-2027 (USD BILLION)
TABLE 32. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, 2018-2027 (USD BILLION)
TABLE 33. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, BY STATE, 2018-2027 (USD BILLION)
TABLE 34. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, 2018-2027 (USD BILLION)
TABLE 35. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, BY STATE, 2018-2027 (USD BILLION)
TABLE 36. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, 2018-2027 (USD BILLION)
TABLE 37. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, BY STATE, 2018-2027 (USD BILLION)
TABLE 38. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2027 (USD BILLION)
TABLE 39. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY STATE, 2018-2027 (USD BILLION)
TABLE 40. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2027 (USD BILLION)
TABLE 41. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY STATE, 2018-2027 (USD BILLION)
TABLE 42. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, 2018-2027 (USD BILLION)
TABLE 43. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY STATE, 2018-2027 (USD BILLION)
TABLE 44. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 45. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
TABLE 46. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD BILLION)
TABLE 47. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
TABLE 48. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD BILLION)
TABLE 49. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, 2018-2027 (USD BILLION)
TABLE 50. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD BILLION)
TABLE 51. CALIFORNIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 52. CALIFORNIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 53. CALIFORNIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 54. FLORIDA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 55. FLORIDA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 56. FLORIDA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 57. ILLINOIS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 58. ILLINOIS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 59. ILLINOIS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 60. NEW YORK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 61. NEW YORK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 62. NEW YORK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 63. OHIO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 64. OHIO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 65. OHIO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 66. PENNSYLVANIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 67. PENNSYLVANIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 68. PENNSYLVANIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 69. TEXAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 70. TEXAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2027 (USD BILLION)
TABLE 71. TEXAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 72. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 73. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 74. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 75. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RANKING, BY KEY PLAYER, 2021
TABLE 76. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 77. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET MERGER & ACQUISITION
TABLE 78. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET INVESTMENT & FUNDING
TABLE 81. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 82. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: LICENSE & PRICING

Companies Mentioned

  • Catalent Inc.
  • Covance Inc.
  • Flex
  • IQVIA Holdings Inc.
  • Jabil
  • Lonza Group Ltd.
  • Recipharm AB
  • Sanmina Corporation
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...